Concepedia

Christoph Markert

CM

9

Publications

521

Citations

9

H-Index

2010

Active since

Affiliations

Heidelberg University(Current)

Heidelberg University

University Hospital Heidelberg

University of Freiburg

Christoph Markert is an author at Heidelberg University specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2010–2021

9

Publications

9

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

Antje Blank, Christoph Markert, Nicolas Hohmann et al. · Journal of Hepatology · 2016 · 214 citations

, , +6

Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy

Stephanie Katzenmaier, Christoph Markert, K. Riedel et al. · Clinical Pharmacology & Therapeutics · 2011 · 134 citations

Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity

Ines Fuchs, Verena Hafner-Blumenstiel, Christoph Markert et al. · European Journal of Clinical Pharmacology · 2012 · 37 citations

, , +7

Proposal of a new limited sampling strategy to predict CYP3A activity using a partial AUC of midazolam

Stephanie Katzenmaier, Christoph Markert, Gerd Mikus · European Journal of Clinical Pharmacology · 2010 · 35 citations · Full text

Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1

Christoph Markert, Regina Hellwig, Jürgen Burhenne et al. · European Journal of Clinical Pharmacology · 2013 · 26 citations

, , +11

Rows per page

1–5 of 9